5-hydroxytryptophan has been researched along with etomidate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerrito, F; Preziosi, P; Vacca, M | 2 |
| Bergström, M; Eriksson, B; Juhlin, C; Långström, B; Oberg, K; Orlefors, H; Sundin, A | 1 |
| Karges, W; Mottaghy, FM; Van Binnebeek, S | 1 |
1 review(s) available for 5-hydroxytryptophan and etomidate
| Article | Year |
|---|---|
The role of PET in localization of neuroendocrine and adrenocortical tumors.
Topics: 5-Hydroxytryptophan; Adrenal Gland Neoplasms; Carbon Radioisotopes; Etomidate; Fluorine Radioisotopes; Humans; Levodopa; Neuroendocrine Tumors; Radioactive Tracers; Tomography, Emission-Computed | 2002 |
3 other study(ies) available for 5-hydroxytryptophan and etomidate
| Article | Year |
|---|---|
Effect of etomidate enantiomers on CRH-ACTH and prolactin release.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Animals; Corticosterone; Corticotropin-Releasing Hormone; Etomidate; Imidazoles; Male; Prolactin; Rats; Stereoisomerism | 1983 |
Etomidate inhibits prolactin release but not through a dopaminergic mechanism.
Topics: 5-Hydroxytryptophan; Animals; Arousal; Brain; Dopamine; Dose-Response Relationship, Drug; Etomidate; Haloperidol; Imidazoles; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stress, Physiological; Synaptosomes | 1983 |
Functional imaging of neuroendocrine tumors.
Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin | 2011 |